Anastasios Apostolos, Dimitrios Tsiachris, Maria Drakopoulou, Georgios Trantalis, Georgios Oikonomou, Nikolaos Ktenopoulos, Chrysavgi Simopoulou, Odysseas Katsaros, Sotirios Tsalamandris, Constantina Aggeli, Georgios Tsivgoulis, Costas Tsioufis, Konstantinos Toutouzas
This comprehensive review explores the incidence, pathophysiology, and management of atrial fibrillation (AF) following percutaneous closure of patent foramen ovale (PFO). Although AF is considered a common adverse event post PFO closure, its incidence, estimated at <5%, varies based on monitoring methods. The review delves into the challenging task of precisely estimating AF incidence, given subclinical AF and diverse diagnostic approaches. Notably, a temporal pattern emerges, with peak incidence around the 14th day after closure and a subsequent decline after the 45th day, mimicking general population AF trends...
April 19, 2024: Journal of the American Heart Association